EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Roles of Protein S -Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential

Haonan Zheng iD, Xiaoyu Sun, Yang Gao, Qinbiao Wang, Jiaqi Wang, Minjie Wei, Yu Tang, Miao He iD

Cancer Communications · 2026

DOI: 10.34133/cancomm.0017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Communications, 2026. Verfasst von Haonan Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Lipoylation, Protein Processing, Post-Translational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein S -palmitoylation is a highly conserved posttranslational lipid modification that occurs on cysteine residues and critically influences protein maturation, subcellular localization, trafficking, and stability. Owing to its unique reversibility and dynamic nature, S -palmitoylation plays a pivotal role in cancer. This review comprehensively summarized the expression profiles and distribution of key cancer-related S -palmitoylation enzymes in recent years. Importantly, we highlight the specific mechanisms by which the dual states of palmitoylation and depalmitoylation function as a dynamic regulatory axis during the transformation of cancer cells into cancer stem cells and during the transition from a normal tissue environment to a tumor microenvironment. Furthermore, we discussed emerging therapeutic strategies targeting S -palmitoylation, including the development of specific inhibitors and competitive blockade of substrate-binding sites, which offer additional insights into the translational potential of S -palmitoylation as a therapeutic target for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLipoylationProtein Processing, Post-TranslationalHumansAnimalsTumor Microenvironment

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China.
  • Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Shenyang, Liaoning, P. R. China.
  • National Health Commission Key Laboratory of Advanced Reproductive Medicine and Fertility (China Medical University), Shenyang, Liaoning, P. R. China.
  • Liaoning Medical Diagnosis and Treatment Center, Shenyang, Liaoning, P. R. China.
  • Department of Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, P. R. China.

ORCID-Profile: Haonan Zheng, Miao He

Zitieren

APA

Zheng, H., Sun, X., Gao, Y., Wang, Q., Wang, J., Wei, M., Tang, Y., & He, M. (2026). The Roles of Protein S -Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential. Cancer Communications. https://doi.org/10.34133/cancomm.0017

Vancouver

Zheng H, Sun X, Gao Y, Wang Q, Wang J, Wei M, et al. The Roles of Protein S -Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential. Cancer Communications. 2026. doi:10.34133/cancomm.0017

BibTeX
@article{Zheng2026,
  author = {Zheng, Haonan and Sun, Xiaoyu and Gao, Yang and Wang, Qinbiao and Wang, Jiaqi and Wei, Minjie and Tang, Yu and He, Miao},
  title = {The Roles of Protein S -Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential},
  journal = {Cancer Communications},
  year = {2026},
  doi = {10.34133/cancomm.0017}
}
Kostenlos starten →